cetylpyridinium chloride anhydrous has been researched along with Benign Monoclonal Gammopathies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alder, H; Aqeilan, RI; Boccadoro, M; Croce, CM; Drandi, D; Garzon, R; Hagan, JP; Kuehl, M; Ladetto, M; Munker, R; Palumbo, A; Palumbo, T; Pichiorri, F; Suh, SS; Taccioli, C; Volinia, S; Zanesi, N | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Benign Monoclonal Gammopathies
Article | Year |
---|---|
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Topics: Animals; Apoptosis Regulatory Proteins; Base Sequence; Bcl-2-Like Protein 11; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Health; Humans; Membrane Proteins; Mice; Mice, Nude; MicroRNAs; Molecular Sequence Data; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; p300-CBP Transcription Factors; Plasma Cells; Proto-Oncogene Proteins; Receptors, Interleukin-6; Repressor Proteins; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Tumor Suppressor Protein p53; Up-Regulation | 2008 |